NCT04000529 2025-09-30Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesNovartisPhase 1 Terminated122 enrolled
NCT04152018 2025-05-28Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.PfizerPhase 1 Terminated85 enrolled
NCT03207867 2024-10-09A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaNovartisPhase 2 Terminated315 enrolled 73 charts
NCT04193293 2023-09-21A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck CancerSecuraBioPhase 1/2 Terminated2 enrolled
NCT04060342 2022-08-18GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaGossamer Bio Inc.Phase 1 Terminated61 enrolled